Daily Sepsis Research Analysis
Analyzed 50 papers and selected 3 impactful papers.
Summary
Mechanistic and translational advances in sepsis highlight ion-channel mediated innate defense, pragmatic immune endotyping using routine labs, and trajectory-guided early warning with real-world mortality benefits. Together, these studies push precision sepsis care from bench discovery to bedside risk stratification and protocolized interventions.
Research Themes
- Ion channel regulation of innate immunity in bacterial sepsis
- Trajectory-based immune and organ dysfunction endotyping
- Explainable machine-learning early warning and protocolized care
Selected Articles
1. Proton-activated chloride channel 1 is essential for innate host defense against bacterial sepsis.
This mechanistic study identifies PACC1 (PAC/ASOR/TMEM206) as a protective factor in sepsis, enriched in mononuclear phagocytes and regulated by inflammatory cues. Findings point to a previously unrecognized ion-channel axis in innate host defense against bacterial sepsis.
Impact: Reveals a novel, targetable ion-channel mechanism underpinning innate defense in sepsis, expanding the therapeutic landscape beyond cytokine-centric approaches.
Clinical Implications: Although preclinical, the work nominates PACC1 as a potential therapeutic target to augment innate immunity in bacterial sepsis and guides biomarker development in phagocyte biology.
Key Findings
- PACC1 exhibits a protective role during sepsis.
- PACC1 is enriched in human and mouse mononuclear phagocytes, particularly macrophages.
- PACC1 expression is differentially regulated by inflammatory stimuli, implicating involvement in innate immunity.
Methodological Strengths
- Focus on a clearly defined molecular entity (PACC1) with cell-specific expression data.
- Integration of human and murine immune cell profiling to support cross-species relevance.
Limitations
- Abstract truncation limits visibility into in vivo functional experiments and outcome measures.
- Translational implications remain inferential pending interventional validation.
Future Directions: Define causal mechanisms linking PACC1 activity to pathogen clearance and survival in sepsis models; evaluate pharmacologic modulators of PACC1 for therapeutic potential.
Bacterial sepsis remains a devastating clinical problem. Here, we describe a protective role for the recently discovered acid-sensitive, proton-activated chloride channel, PACC1 (PAC/ASOR/TMEM206), during sepsis. Initially, we found PACC1 was enriched in healthy human and mouse mononuclear phagocytes, particularly macrophages, and differentially regulated by inflammatory stimuli, suggesting PACC1 involvement in innate immunity. To further investigate, we generated
2. Dynamic trajectories of organ dysfunction in sepsis using the SOFA-2 score and early prediction from multicenter cohorts.
In 18,452 ICU sepsis admissions, three reproducible SOFA-2 trajectories were identified with markedly different 28-day mortality. An explainable early-warning model predicted unfavorable trajectories within 72 hours (AUROC 0.84–0.88) and, after protocolized alerts, implementation was associated with reduced mortality and resource use.
Impact: Establishes clinically actionable organ-dysfunction trajectories and validates an early prediction-alert workflow associated with improved outcomes across multicenter datasets.
Clinical Implications: Daily SOFA-2 trajectory tracking with explainable ML prediction enables early multidisciplinary reassessment and protocolized optimization of infection control and organ support, potentially lowering mortality.
Key Findings
- Three SOFA-2 trajectories (rapid recovery 36.2%, delayed recovery 45.0%, unfavorable 18.8%) had 28-day mortality of 11.3%, 23.7%, and 52.4%, respectively.
- An early prediction model using the first 72 hours achieved AUROCs of 0.88 (development), 0.86 (temporal validation), and 0.84–0.86 (external validation) with a median 36-hour lead time.
- After real-world implementation, trajectory-guided alerts were associated with lower 28-day mortality (27.0% vs 21.7%; risk difference −5.3%; P=0.002) and reduced ICU LOS and vasopressor duration.
Methodological Strengths
- Large multicenter cohorts with internal, temporal, and external validation.
- Explainable machine-learning and real-world implementation evaluation.
Limitations
- Retrospective design with potential residual confounding in the implementation analysis.
- SOFA-2 trajectories and alerts were not tested in randomized controlled trials.
Future Directions: Prospective, randomized testing of trajectory-guided care and integration with immune endotyping to tailor organ support and adjunctive therapies.
OBJECTIVES: The Sequential Organ Failure Assessment-2 (SOFA-2) score reflects contemporary intensive care practices, yet its longitudinal application in sepsis remains unexplored. METHODS: We conducted a multicentre retrospective cohort study of 18,452 adult ICU admissions meeting Sepsis-3 criteria from a Chinese tertiary hospital and two US public databases (MIMIC-IV, eICU) to characterize 14-day organ dysfunction trajectories, develop an ensemble machine-learning model for early trajectory prediction, and evaluate real-world implementation of protocolized alerts. RESULTS: Group-based trajectory modelling identified three reproducible patterns-rapid recovery (36.2%), delayed recovery (45.0%) and an unfavorable trajectory characterized by persistent/severe dysfunction (18.8%)-with 28-day mortality rates of 11.3%, 23.7% and 52.4%, respectively (P < 0.001). The prediction model, trained on data from the first 72 h of ICU stayto predict this unfavorable trajectory, achieved AUROCs of 0.88 (development), 0.86 (temporal validation) and 0.84-0.86 (external validation), providing a median 36-h lead time. After implementation, the alert protocol was associated with a lower 28-day mortality (27.0% vs 21.7%; risk difference -5.3%; P = 0.002), along with shorter ICU length of stay and vasopressor duration. CONCLUSIONS: Dynamic SOFA-2 trajectories offer high-resolution risk stratification, and early, explainable machine-learning prediction coupled with trajectory-guided alerts may improve survival and resource utilization in sepsis, supporting their integration into precision critical care workflows. IMPLICATIONS FOR CLINICAL PRACTICE: Daily SOFA-2 trajectory tracking can support early, individualized risk stratification in sepsis beyond single time-point scores. An explainable early-warning model can predict unfavorable trajectories within the first 72 h.This lead time enables timely multidisciplinary review and protocolized optimization of infection control and organ support, which may ultimately improve patient outcomes and resource utilization.
3. Identification of distinct immune subtypes in sepsis through dual immunomarker trajectory.
Using longitudinal CRP and absolute lymphocyte count within four ICU days, investigators defined three reproducible immune subtypes with distinct severity, PICS incidence, and mortality, validated across internal and external cohorts. The approach offers a simple, clinically actionable endotyping method suitable for resource-limited settings.
Impact: Translates complex immune endotyping into a pragmatic, trajectory-based classification using routine labs, enabling timely risk stratification and potential therapy alignment.
Clinical Implications: CRP–ALC trajectories can guide early identification of immunosuppressed or immune-imbalanced patients at risk of PICS and death, informing monitoring intensity and consideration of immunomodulatory strategies.
Key Findings
- Three immune subtypes were derived from CRP and ALC dynamics: immune homeostasis (8.3%), immunosuppression (38.2%), and immune imbalance (53.5%).
- Subtypes differed in clinical outcomes: immune homeostasis had the lowest PICS and mortality; immunosuppression had more comorbidities, longer hospitalization, and higher mortality; immune imbalance had the highest complications, ICU stay, PICS, and mortality.
- Immune profiling showed distinct biology: immune imbalance exhibited cytokine storm and severely impaired innate/adaptive immunity with low mHLA-DR and deficient late T-cell activation.
Methodological Strengths
- Large multi-cohort design with internal and external validation.
- Group-based multi-trajectory modeling using readily available biomarkers and extended immune profiling.
Limitations
- Observational design limits causal inference regarding treatment responsiveness by subtype.
- Potential measurement timing variability within the 4-day window could introduce misclassification.
Future Directions: Prospective trials testing immunomodulatory strategies stratified by CRP–ALC trajectories; integration with transcriptomic endotypes for adaptive trial enrichment.
BACKGROUND: While endotyping approaches have enhanced precision immunotherapy in sepsis, their temporal instability limits consistent clinical application. To overcome this challenge, the current study utilizes longitudinal immune markers to derive clinically relevant classifications. METHODS: This study included three cohorts of 3,223 adult septic patients with at least three measurements of two readily available longitudinal immune markers, C-reactive protein (CRP) and absolute lymphocyte count (ALC), within four days following ICU admission. Group-based multi-trajectory modeling was used to cluster sepsis patients based on the dynamic changes of CRP and ALC to identify potential immune subgroups. Comparisons of clinical characteristics, hospital mortality, and persistent inflammation immunosuppression catabolism syndrome (PICS) incidence were made across the derived subgroups. We further characterized the immune-specific properties of each subgroup using 28 immune markers. RESULTS: Based on the optimal classification, 471 sepsis patients in the derivation cohort were categorized into three subgroups: immune homeostasis subgroup (n = 39, 8.3%), immunosuppression subgroup (n = 180, 38.2%), and immune imbalance subgroup (n = 252, 53.5%). This classification remained robust upon validation in both internal (n = 2,527) and external (n = 225) cohorts. Differences in clinical profiles were observed in these subgroups: the immune homeostasis subgroup had the mildest disease severity with the lowest rates of PICS and mortality; the immunosuppression subgroup featured more chronic comorbidities, longer hospital stays, and higher mortality; while the immune imbalance subgroup exhibited the most critical condition, with more complications, longer ICU stays, and the highest incidence of PICS and mortality. Immune features revealed distinct subtype properties: the immune homeostasis subgroup exhibited inflammatory resolution and near-normal immunity; the immunosuppression subgroup characterized by a general reduction in lymphocyte subsets, persistent early T-cell activation, and the highest degree of T cell inhibition; and the immune imbalance subgroup showed a cytokine storm alongside the most severely impaired innate and adaptive immunity, as indicated by markedly low monocyte human leukocyte antigen-DR (mHLA-DR) expression and deficient late T cell activation. CONCLUSIONS: This study presents a practical immunological classification for sepsis based on the longitudinal dynamics of two immune markers. These immune subtypes complement existing consensus endotypes and provide a simple, clinically actionable approach particularly applicable in resource-limited settings.